興科蓉醫藥：2021中期報告.pdf

1、2021INTERIM REPORT中期報告INTERIM REPORT中期報告Contents目錄2Corporate Information公司資料4Financial Highlights財務摘要6Corporate Profile公司簡介7Management Discussion and Analysis管理層討論及分析24Other Information其他資料33Independent Review Report獨立審閱報告35Interim Condensed Consolidated Statement of Profit or Loss and Other Compreh

2、ensive Income中期簡明綜合損益及其他全面收益表36Interim Condensed Consolidated Statement of Financial Position中期簡明綜合財務狀況表38Interim Condensed Consolidated Statement of Changes in Equity中期簡明綜合權益變動表39Interim Condensed Consolidated Statement of Cash Flows中期簡明綜合現金流量表41Notes to Interim Condensed Financial Information中期簡明財

3、務資料附註74Definitions釋義2Sinco Pharmaceuticals Holdings Limited Interim Report 2021Corporate Information公司資料BOARD OF DIRECTORSExecutive DirectorsMr.Huang Xiangbin(Chairman and Co-Chief Executive Officer)Ms.Zhang Zhijie(resigned on 8 January 2021)Independent Non-executive DirectorsMr.Lau Ying KitMr.Liu W

4、enfangMr.Wang QingMr.Bai ZhizhongAUDIT COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Liu WenfangMr.Wang QingMr.Bai ZhizhongREMUNERATION COMMITTEEMr.Wang Qing(Chairman)Mr.Liu WenfangMr.Bai Zhizhong(appointed on 8 January 2021)NOMINATION COMMITTEEMr.Huang Xiangbin(Chairman)Mr.Liu WenfangMr.Lau Ying KitINTERNAL

5、 CONTROL AND CORPORATE GOVERNANCE COMMITTEEMr.Lau Ying Kit(Chairman)Mr.Wang QingMr.Liu WenfangMr.Bai ZhizhongAUTHORISED REPRESENTATIVESMr.Huang XiangbinMr.Li Kin Wai(appointed on 31 March 2021)Ms.Li Ching Yi(resigned on 22 January 2021)Ms.Wong Yik Han(appointed on 22 January 2021 andresigned on 31 M

6、arch 2021)JOINT COMPANY SECRETARIESMs.Peng YunluMr.Li Kin Wai(appointed on 31 March 2021)Ms.Li Ching Yi(resigned on 22 January 2021)Ms.Wong Yik Han(appointed on 22 January 2021 andresigned on 31 March 2021)董事會執行董事黃祥彬先生（主席兼聯席行政總裁）張志傑女士（於2021年1月8日辭任）獨立非執行董事劉英傑先生劉文芳先生汪晴先生白志中先生審核委員會劉英傑先生（主席）劉文芳先生汪晴先生白志中